Search

everythinglearnresearchcommunity

for

Search:↓

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Hirsutism causes significant psychological distress in women.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

Saw palmetto is an effective natural treatment for hair loss with minimal side effects.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

OCT can effectively screen and diagnose various medical conditions non-invasively.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Androgens can cause hair growth in some areas and hair loss on the scalp.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

DHT, a testosterone byproduct, causes male pattern baldness.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Finasteride doesn't affect hormone levels in normal men.